Author
Listed:
- Jason S. Wasserman
(Fels Cancer Institute for Personalized Medicine. Temple University Lewis Katz School of Medicine)
- Bulat Faezov
(Temple Health
Kazan Federal University)
- Kishan R. Patel
(Fels Cancer Institute for Personalized Medicine. Temple University Lewis Katz School of Medicine)
- Alison M. Kurimchak
(Temple Health)
- Seren M. Palacio
(Fels Cancer Institute for Personalized Medicine. Temple University Lewis Katz School of Medicine)
- David J. Glass
(Temple Health)
- Holly Fowle
(Fels Cancer Institute for Personalized Medicine. Temple University Lewis Katz School of Medicine)
- Brennan C. McEwan
(Medical Center Drive)
- Qifang Xu
(Temple Health)
- Ziran Zhao
(Fels Cancer Institute for Personalized Medicine. Temple University Lewis Katz School of Medicine)
- Lauren Cressey
(Medical Center Drive)
- Neil Johnson
(Temple Health)
- James S. Duncan
(Temple Health)
- Arminja N. Kettenbach
(Medical Center Drive)
- Roland L. Dunbrack
(Temple Health)
- Xavier Graña
(Fels Cancer Institute for Personalized Medicine. Temple University Lewis Katz School of Medicine
Temple Health)
Abstract
The Ser/Thr protein phosphatase 2 A (PP2A) regulates the dephosphorylation of many phosphoproteins. Substrate recognition are mediated by B regulatory subunits. Here, we report the identification of a substrate conserved motif [RK]-V-x-x-[VI]-R in FAM122A, an inhibitor of B55α/PP2A. This motif is necessary for FAM122A binding to B55α, and computational structure prediction suggests the motif, which is helical, blocks substrate docking to the same site. In this model, FAM122A also spatially constrains substrate access by occluding the catalytic subunit. Consistently, FAM122A functions as a competitive inhibitor as it prevents substrate binding and dephosphorylation of CDK substrates by B55α/PP2A in cell lysates. FAM122A deficiency in human cell lines reduces the proliferation rate, cell cycle progression, and hinders G1/S and intra-S phase cell cycle checkpoints. FAM122A-KO in HEK293 cells attenuates CHK1 and CHK2 activation in response to replication stress. Overall, these data strongly suggest that FAM122A is a short helical motif (SHeM)-dependent, substrate-competitive inhibitor of B55α/PP2A that suppresses multiple functions of B55α in the DNA damage response and in timely progression through the cell cycle interphase.
Suggested Citation
Jason S. Wasserman & Bulat Faezov & Kishan R. Patel & Alison M. Kurimchak & Seren M. Palacio & David J. Glass & Holly Fowle & Brennan C. McEwan & Qifang Xu & Ziran Zhao & Lauren Cressey & Neil Johnson, 2024.
"FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs,"
Nature Communications, Nature, vol. 15(1), pages 1-20, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50015-7
DOI: 10.1038/s41467-024-50015-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50015-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.